HOME >> MEDICINE >> NEWS
Icahn invests in the future of medicine

The Mount Sinai Medical Center today announced that foundations funded by Carl C. Icahn have committed $25 million to the Medical Center. The gift to The Mount Sinai Medical Center will help support research at Mount Sinai School of Medicine, which has the fastest growing research program in New York State. In recognition of his generosity, a state-of-the-art research building on the Mount Sinai campus, 1425 Madison Avenue, will be named The Icahn Medical Institute.

"We are delighted to receive this tremendously generous donation," said Peter W. May, the Chairman of the Boards of Trustees of The Mount Sinai Medical Center. "The fiscal challenges facing all academic medical centers give particular weight to the message of support inherent in this gift."

"This gift will help support researchers who are expanding our understanding of health and disease at the molecular, cellular, system and whole body level; identifying the underlying causes of diseases; developing new therapies; and bringing our patients tomorrow's medicine today," said Kenneth L. Davis, M.D., President and CEO of The Mount Sinai Medical Center and Dean of Mount Sinai School of Medicine.

Mr. Icahn said, "I've successfully made money through discerning which investments have the greatest potential for return. The numerous Mount Sinai generated discoveries that have been translated into improvements in patient care and its ranking among the nation's top medical schools provide an excellent basis for me to expect rich rewards for society from this investment."

A landmark of the Upper East Side skyline, the building to be named for Mr. Icahn was designed by the architectural firm Davis Brody Bond, LLP and was completed in 1997. It is home to scientists searching for answers to some of the most puzzling questions in contemporary biomedical science. This building has provided the space and facilities necessary for Mount Sinai School of Medicine to greatly expand its research progra
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
24-Feb-2004


Page: 1 2

Related medicine news :

1. Concerns over the future of childrens health care in British general practice
2. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
3. HIV vaccine trial breaks ground for future research
4. Climate change and the future of air travel
5. NIH action plan charts future challenges for liver disease research
6. Obesity in middle age may drastically raise future medicare expenditures
7. Stem cell research: The new medicine of the future
8. Chemoprevention backgrounder: Working for a future of cancer chemoprevention
9. Asymptomatic cardiovascular changes are powerful predictor of future heart disease
10. Heat-controlled drug implants offer hope for future
11. Envisat Symposium report day 3: Satellites supporting Kyoto - our future is in our forests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Icahn invests the future medicine

(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters ... facility is a state of the art building, located with easy access to New ... founder, said, "We are pleased to service our clients from such a premier location ...
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting revolutionary purity limits for ... Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some of ... to test every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of teenagers or young ... an open-ended holistic treatment center for drug and alcohol abuse located in Southwest Michigan. ... Research has shown a significant increase in the “club drug” use among high school ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... promotion on teeth whitening treatments. A professional teeth whitening is one of the fastest, ... appearance, as well as they can decrease smile satisfaction and confidence. With the right ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... new generation of drugs within human and veterinary oncology, ... the Securities and Exchange Commission, in connection with the ... the NASDAQ Stock Market. The number of American Depositary ... price range for the offering have not yet been ...
(Date:7/7/2015)... July 7, 2015  Monopar Therapeutics LLC, an emerging ... that its co-founder and CEO, Chandler D. Robinson ... U.K. Alumni Entrepreneurial Award. The British Council selected one ... India , and the ... made by entrepreneurs who have leveraged their U.K. education ...
(Date:7/7/2015)... DIEGO , July 7, 2015   ... announced today initiation of enrollment and dosing of ... study of ABX-1431, a first-in-class, investigational endocannabinoid system ... platform, which finds new small molecule drug candidates ... enzymes with important regulatory roles in human physiology ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 2Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 3
Cached News: